Cover Image
市場調查報告書

人工神經的全球全球市場:2015∼2019年

Global Neuroprosthetics Market 2015-2019 - Industry research report

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 341179
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
人工神經的全球全球市場:2015∼2019年 Global Neuroprosthetics Market 2015-2019 - Industry research report
出版日期: 2015年09月30日 內容資訊: 英文 78 Pages
簡介

人工神經是融合神經科學和生物醫學工程設計而成的植入式裝置。利用電氣刺激來改善罹患的神經系統之機能。全球人工神經市場預測在2014∼2019年間將以年複合成長率7.08%擴大。

本報告提供全球人工神經市場現狀及2015∼2019年的成長預測相關調查,為您彙整市場規模,各用途,各地區趨勢,及主要供應商簡介等資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 人工神經的償付

  • 美國
  • 歐洲
  • 亞太地區

第6章 新興技術

  • 腦和電腦的介面

第7章 近幾年的市場上核准

第8章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第9章 各用途市場市場區隔

第10章 全球認知裝置市場

第11章 全球神經調整設備市場

第12章 各技術市場區隔

第13章 各地區市場市場區隔

  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第14章 推動市場的要素

  • 神經疾病的罹患率上升
  • 研究開發費的資金取得
  • 許多產品認證
  • 第二次的治療

第15章 推動市場要素的影響

第16章 市場課題

  • 電池壽命
  • 與MRI,X光掃描,超音波設備的兼容性受限
  • 給付方案受限
  • 媒介GPO
  • 嚴格的法律規章
  • 成本控制策略

第17章 促進要素與課題的影響

第18章 市場趨勢

  • 海外擴大
  • 混合型人工神經設備
  • 下一代中樞神經疾病治療
  • 美觀的人工神經
  • 在美軍的使用

第19章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2013年
  • 其他值得注意的供應商

第20章 主要供應商分析

  • Boston Scientific
  • Cochlear
  • MED-EL
  • Medtronic
  • Sonova
  • St. Jude Medical

第21章 附錄

第22章 關於Technavio

圖表

目錄
Product Code: IRTNTR7193

About neuroprosthetics

Neuroprosthetics are implantable devices designed by combining neuroscience and biomedical engineering. These artificial implantable devices provide electrical stimulation that improves the functionality of a diseased nervous system. These devices either are implanted inside the body or can be worn externally. These are used either to replace a lost function of the body such as cognitive ability or to treat neurological conditions such as depression, chronic pain, epilepsy, or spinal cord injuries. Based on application, neuroprosthetics are segmented into cognitive devices and neuromodulation devices. Based on technology, neuroprosthetics are segmented into SCS system, DBS system, SNS system, VNS system, and others.

Technavio's analysts forecast the global neuroprosthetics market to grow at a CAGR of 7.08% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global neuroprosthetics market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of cochlear implants and neuromodulators.

Based on application, the market is segmented into the following:

  • Cognitive devices (cochlear implants)
  • Neuromodulation devices

Based on technology, the market is segmented into the following:

  • SCS system
  • DBS system
  • SNS system
  • VNS system
  • Others (transcranial magnetic stimulation, peripheral nerve stimulation, gastric electrical stimulation, diaphragm pacing, lower esophageal sphincter stimulation, and cortical stimulation systems)

Technavio's report, Global Neuroprosthetics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global neuroprosthetics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Boston Scientific
  • Cochlear
  • MED-EL
  • Medtronic
  • Sonova
  • St. Jude Medical

Other Prominent Vendors

  • Autonomic Technologies
  • BrainGate
  • electroCore
  • Mainstay Medical
  • NeuroPace
  • Nevro
  • Oticon Medical
  • Soterix Medical

Key market driver

  • Growing prevalence of neurological disorder
  • For a full, detailed list, view our report

Key market challenge

  • Battery lifetime
  • For a full, detailed list, view our report

Key market trend

  • Overseas expansion
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Reimbursement for neuroprosthetics

  • Reimbursement in US
  • Reimbursement in Europe
  • Reimbursement in APAC

PART 06: Emerging technologies in neuroprosthetics

  • Brain-computer interface

PART 07: Recent market approvals

PART 08: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 09: Market segmentation by application

  • Global neuroprosthetics market segmentation by application

PART 10: Global cognitive devices market

  • Market overview
  • Market size and forecast

PART 11: Global neuromodulation devices market

  • Market overview
  • Market size and forecast

PART 12: Market segmentation by technology

  • Global neuroprosthetics market segmentation by technology

PART 13: Geographical segmentation

  • Neuroprosthetics market in Americas
  • Neuroprosthetics market in EMEA
  • Neuroprosthetics market in APAC

PART 14: Market drivers

  • Increased prevalence of neurological disorders
  • Availability of funds for R&D
  • Numerous product approvals
  • Second-line treatment

PART 15: Impact of drivers

PART 16: Market challenges

  • Battery lifetime
  • Limited compatibility with MRI, X-ray, and ultrasound equipment
  • Limited reimbursement scenario
  • GPOs as intermediary
  • Stringent regulations
  • Cost containment

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Overseas expansions
  • Hybrid neuroprosthetic devices
  • Next-generation therapies for CNS disorders
  • Aesthetically appealing prosthetics
  • Use in US military

PART 19: Vendor landscape

  • Competitive scenario
  • Market share analysis 2013
  • Other prominent vendors

PART 20: Key vendor analysis

  • Boston Scientific
  • Cochlear
  • MED-EL
  • Medtronic
  • Sonova
  • St. Jude Medical

PART 21: Appendix

  • List of abbreviations

PART 22: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Reimbursement of neuroprosthetics in US
  • Exhibit 03: Reimbursement of neuroprosthetics in major European countries
  • Exhibit 04: Emerging neuroprosthetics and approval dates
  • Exhibit 05: Approved neuroprosthetics 2015
  • Exhibit 06: Global neuroprosthetics market 2014-2019 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Global neuroprosthetics market segmentation by application 2014
  • Exhibit 09: Global cochlear implants market 2014-2019 ($ billions)
  • Exhibit 10: Global neuromodulation devices market 2014-2019 ($ billions)
  • Exhibit 11: Global neuroprosthetics market segmentation by technology 2014
  • Exhibit 12: Global SCS system market 2014-2019 ($ billions)
  • Exhibit 13: Global DBS system market 2014-2019 ($ millions)
  • Exhibit 14: Global SNS system market 2014-2019 ($ millions)
  • Exhibit 15: Global VNS system market 2014-2019 ($ millions)
  • Exhibit 16: Global neuroprosthetics market segmentation by geography 2014
  • Exhibit 17: Neuroprosthetics market in Americas 2014-2019 ($ millions)
  • Exhibit 18: Neuroprosthetics market in EMEA 2014-2019 ($ billions)
  • Exhibit 19: Neuroprosthetics market in APAC 2014-2019 ($ billions)
  • Exhibit 20: Impact of drivers
  • Exhibit 21: Impact of drivers and challenges
  • Exhibit 22: Top vendors in cognitive devices market 2014
  • Exhibit 23: Cochlear: Key takeaways
  • Exhibit 24: MED-EL: Key takeaways
  • Exhibit 25: Sonova Holding: Key takeaways
  • Exhibit 26: Global neuromodulation devices market share analysis 2014
  • Exhibit 27: Medtronic: Key takeaways
  • Exhibit 28: Boston Scientific: Key takeaways
  • Exhibit 29: St. Jude Medical: Key takeaways
  • Exhibit 30: Cochlear: Business segmentation by revenue 2014
  • Exhibit 31: Cochlear: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 32: MED-EL: Product offerings
  • Exhibit 33: Sonova: Business segmentation
  • Exhibit 34: Sonova: Business segmentation by revenue 2015
  • Exhibit 35: Sonova: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 36: Sonova: Geographical segmentation by revenue 2014
Back to Top